Canadian biotech firm plans Sachse manufacturing facility, hundreds of hires

SourceThe Business Journal
Date Published12/06/2021
Author NameKevin Cummings
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Evolve Biologics
Parent companyEvolve
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Total number of jobs (added or to be added):300
Year reshoring announced:2021
Year reshoring implemented or to be implemented:2022
Capital investment ($):100
Country(ies) from which reshored:Canada
City reshored to:Sachse
State(s) reshored to:TX
If relevant, work nearshored to:-
Product(s) reshoredplasma
What domestic positive factors made reshoring more attractive?Eco-system synergies, Skilled workforce availability/training
Find Reshoring Articles